Recent Updates
Recently added Catalysts
RGEN Positive Sentiment

Repligen Corporation to Present at Upcoming Investor Conferences

Tuesday, November 5, 2024 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Repligen Corporation has announced its participation in three upcoming investor conferences. The events include the UBS Global Healthcare Conference, the Stifel Healthcare Conference, and the Stephens Annual Investment Conference, scheduled between November 11 and November 21, 2024. Key executives, including the CEO and CFO, will engage in analyst-led discussions, providing a platform to showcase their bioprocessing technology leadership.
Price reaction · baseline $139.53 (2024-11-04 close) · hit after-hours · clean, no other RGEN news in the window
day 0 close · peak
+4.6%

Conference Participation Details

UBS Global Healthcare Conference
Date: November 11, 2025
Time: 8:45 a.m. ET
Format: Fireside Chat

How to Access

Investors and the general public can listen to both sessions live at:

https://investor.viatris.com

Archived versions will be available following the live events for a limited time.

Market Sentiment Analysis

POSITIVE FACTORS

  • Repligen Corporation will showcase its bioprocessing technology at key investor conferences.
  • Participation in multiple high-profile events highlights company's industry relevance.
  • Opportunity for executives to engage directly with investors and analysts.

Full Press Release Details

WALTHAM, Mass., Nov. 05, 2024 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it will be presenting at three upcoming investor conferences.
The UBS Global Healthcare Conference being held November 11-14 in Rancho Palos Verdes, CA. Jason Garland, Chief Financial Officer, will participate in an analyst-led discussion on Thursday, November 14, at 10:15 a.m. ET.
The Stifel Healthcare Conference being held November 18-19 in New York City. Olivier Loeillot, Chief Executive Officer, and Jason Garland, Chief Financial Officer, will participate in an analyst-led discussion on Tuesday, November 19, at 12:40 p.m. ET.
The Stephens Annual Investment Conference being held November 19-21 in Nashville. Olivier Loeillot, Chief Executive Officer, and Jason Garland, Chief Financial Officer, will participate in an analyst-led discussion on Wednesday, November 20, at 10:00 a.m. ET.
A live webcast of the conference presentations will be accessible through Repligen’s Investor Relations website at www.repligen.com, and will be available for replay for a limited period of time following the event.
About Repligen Corporation

Frequently Asked Questions

When is Repligen presenting at the UBS Conference?

Repligen will present at the UBS Global Healthcare Conference on November 14.

Who will represent Repligen at the Stifel Conference?

Olivier Loeillot and Jason Garland will represent Repligen at the Stifel Conference.

Where can I watch Repligen's conference presentations?

The live webcasts of the presentations will be available on Repligen's Investor Relations website.

What date is the Stephens Annual Conference scheduled?

The Stephens Annual Investment Conference is scheduled for November 19-21.

Who will participate in the analyst-led discussion at Stephens?

Olivier Loeillot and Jason Garland will participate in the discussion at Stephens.

ShareAdd on Google
Tags: RGEN Viatris Investor Conferences Healthcare Repligen investor conferences bioprocessing technology NASDAQ:RGEN healthcare
Last updated: Nov 5, 2024

Conference Timeline

Nov 11, 2025
UBS Global Healthcare Conference
8:45 AM ET • Fireside Chat
Nov 18, 2025
Jefferies Global Healthcare
11:30 AM GMT • London

Biotech snapshot

Cash runway
$810M liquidity · $0M/mo burn
Low dilution risk
Lead asset
RG2417Phase 2
Bipolar I Depression →